Tang Capital Management »

Bolt Biotherapeutics shares owned by Tang Capital Management

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $356k 67k 5.32
2025-06-30 $963k 167k 5.77

More positions owned by Tang Capital Management

Tarsus Pharmaceuticals (TARS)
Galapagos Nv Spon Adr (GLPG)
Aurinia Pharmaceuticals (AUPH)
Ptc Therapeutics I (PTCT)
Mirum Pharmaceuticals (MIRM)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Immunocore Hldgs Ads (IMCR)
Kalvista Pharmaceuticals (KALV)
Miragen Therapeutics (VRDN)
Compass Therapeutics (CMPX)
Celcuity (CELC)
Merus N V (MRUS)
Spyre Therapeutics Com New (SYRE)
Relay Therapeutics (RLAY)
Lenz Therapeutics (LENZ)

View all positions for Tang Capital Management

Top funds holding Bolt Biotherapeutics

Vivo Capital
Sofinnova Ventures
Pivotal bioVenture Partners Investment Advisor
Tang Capital Management
Nan Fung Group Holdings
Samsara BioCapital
Board of Trustees of The Leland Stanford Junior University
Vanguard Group
Pfizer
Renaissance Technologies
Geode Capital Management
Susquehanna International
Shay Capital
Squarepoint Ops
DRW Holdings

View all funds holding Bolt Biotherapeutics